Position in QGEN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,414,400
New position
Shares Held
360,000
first reported quarter
Ownership
0.174%
of shares outstanding
% of Portfolio
1.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Casdin Capital, LLC holds $469,206,926 across 7 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WGS |
GeneDx Holdings Corp.
|
3,707,164 | $254,496,808 | |
| 2 | ILMN |
Illumina, Inc.
|
530,000 | $93,189,900 | |
| 3 | PSNL |
Personalis, Inc.
|
2,550,000 | $34,170,000 | |
| 4 | GRAL |
GRAIL, Inc.
|
480,000 | $32,769,600 | |
| 5 | GH |
Guardant Health, Inc.
|
185,000 | $27,755,550 | |
| 6 | VCYT |
Veracyte, Inc.
|
276,308 | $16,227,568 | |
| 7 | DGX |
Quest Diagnostics Inc
|
50,000 | $10,597,500 |
All Filings in QGEN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,414,400 | 360,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||